NDC 63323-516-01 - Dexamethasone Sodium Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-516
- Requested NDC
- 63323-516-01
- Package NDCs from labels
- 63323-516-01, 63323-516-10
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2026-06-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexamethasone Sodium Phosphate - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2026-06-30 | HUMAN PRESCRIPTION DRUG LABEL |
| DEXAMETHASONE SODIUM PHOSPHATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2026-03-23 | HUMAN PRESCRIPTION DRUG LABEL |
| Dexamethasone Sodium Phosphate - A-S Medication Solutions | A-S Medication Solutions | 2021-04-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-516-01 | Dexamethasone Sodium Phosphate | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 11 | |
| 63323-516-10 | Dexamethasone Sodium Phosphate | 10 in 1 TRAY | INJECTION, SOLUTION | 10 | 11 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-516-01 | ML - Milliliter | 63323-516 | 3730edd9-e959-4a29-8817-9a8f025b511a | 1 | 2024-11-05 |
| 63323-516-10 | ML - Milliliter | 63323-516 | d7f3c390-399d-47c9-94c4-a130752907ea | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DEXAMETHASONE SODIUM PHOSPHATE | ACTIVE INGREDIENT | AI9376Y64P | DEXAMETHASONE SODIUM PHOSPHATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| DEXAMETHASONE | ACTIVE MOIETY | 7S5I7G3JQL | DEXAMETHASONE SODIUM PHOSPHATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | DEXAMETHASONE SODIUM PHOSPHATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | DEXAMETHASONE SODIUM PHOSPHATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | DEXAMETHASONE SODIUM PHOSPHATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | DEXAMETHASONE SODIUM PHOSPHATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Quality Choice Eye Wash | WATER | Chain Drug Marketing Assoc., Inc. | 1fb8a109-351b-7039-e063-6394a90a7311 | 2025-12-30 | Warnings | 059QF0KO0R |
| Rite Aid Eye Wash | PURIFIED WATER | Rite Aid | 28a18e04-d735-a511-e063-6394a90af6bb | 2025-12-30 | Warnings | 059QF0KO0R |
| OCUFRESH | WATER | Optics Laboratory Inc. | b8e477a9-66b9-496b-92fb-3d4bbd7b36b5 | 2025-12-29 | Warnings | 059QF0KO0R |
| Kollourion Eyesalve Eyewash | PURIFIED WATER 98.3% | Miracle Eye Pharmaceuticals | b56d2ab9-169b-b490-e053-2a95a90a80b3 | 2025-12-28 | Warnings | 059QF0KO0R |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Fresenius Kabi USA, LLC | ce25183b-cd67-4997-8de9-df59b750883b | 2025-12-24 | Warnings, Adverse reactions | AI9376Y64P |
| Sterile Cord Blood Collection Unit (MSC128D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION | Maco Productions | 251fd4cb-4aa4-4473-9f89-968da856eb77 | 2025-12-18 | Warnings | 2968PHW8QP 1Q73Q2JULR |
| Sterile Cord Blood Collection Unit (MSC127D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION | Maco Productions | 75a008b2-9666-4bfa-ab18-6d09b43b2215 | 2025-12-18 | Warnings | 2968PHW8QP 1Q73Q2JULR |
| Pall Sterile Cord Blood Collection Unit | STERILE CORD BLOOD COLLECTION UNIT | Global Life Sciences Solutions USA LLC | aa9340b7-cc63-e17d-e053-2a95a90ad4d9 | 2025-12-18 | Warnings | 2968PHW8QP 1Q73Q2JULR |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | ProPharma Distribution | 384206f5-75ed-9bd2-e063-6294a90a5038 | 2025-12-18 | Warnings, Adverse reactions | AI9376Y64P |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | ProPharma Distribution | 42c879cc-38dc-c9bc-e063-6294a90a204d | 2025-12-18 | Warnings, Adverse reactions | AI9376Y64P |
| Hepatatox | TRITICUM AESTIVUM, CHELIDONIUM MAJUS, TARAXACUM OFFICINALE, GLUTATHIONE, HEPAR SUIS, THYROIDINUM (SUIS), LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, ADRENOCORTICOTROPHIN, SALICYLICUM ACIDUM, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, PHENYL BUTAZONE, PETROLEUM JELLY, PLUMBUM METALLICUM | BioActive Nutritional, Inc | a113a9f1-4792-41a5-8d1b-a6756f356e15 | 2025-12-18 | Warnings | LKG8494WBH |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Fresenius Kabi USA, LLC | 4dd55929-fe0a-4884-ae0d-6f9435920eb7 | 2025-12-17 | Warnings, Adverse reactions | AI9376Y64P |
| STERILE CORD BLOOD COLLECTION UNIT (MSC123D) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE | Maco Productions | e3b456ec-4578-485f-a696-8a343505f30b | 2025-12-16 | Warnings | 2968PHW8QP 1Q73Q2JULR |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Fresenius Kabi USA, LLC | 88d25d19-acff-477b-86c8-9797782045b8 | 2025-12-11 | Warnings, Adverse reactions | AI9376Y64P |
| Firstep Firstflush | EYEWASH | Encon Safety Products, Inc. | a44beb26-79ae-98bd-e053-2995a90a9b74 | 2025-12-09 | Warnings | 059QF0KO0R |
| PaxLyte | LEUCOVORIN, FOLIC ACID, LEVOMEFOLATE MAGNESIUM, FERROUS CYSTEINE GLYCINATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, PHOSPHATIDYL SERINE, PYRIDOXAL 5-PHOSPHATE, FLAVIN ADENINE DINUCLEOTIDE, NADH, COBAMAMIDE, COCARBOXYLASE (THIAMINE PYROPHOSPHATE), MAGNESIUM ASCORBATE, ZINC ASCORBATE, MAGNESIUM L-THREONATE AND BETAINE CAPSULE | Jaymac Pharmaceuticals | f520b130-61b3-443e-aaf6-91e094e7a334 | 2025-12-08 | Warnings, Adverse reactions | 2968PHW8QP 1Q73Q2JULR |
| Alka-Seltzer Heartburn | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE (HEAT-TREATED) | Bayer HealthCare LLC. | 55158e50-0327-2043-e054-00144ff8d46c | 2025-12-04 | Warnings | 2968PHW8QP |
| Alka-Seltzer Gold | ALKA-SELTZER GOLD | Bayer HealthCare LLC. | 0824bedb-413b-2fa0-e054-00144ff88e88 | 2025-12-04 | Warnings | 2968PHW8QP |
| Thermacare Max Strength Lidocaine | THERMACARE MAX STRENGTH LIDOCAINE | Clarion Brands LLC | 44fed887-d1e0-d205-e063-6294a90ac416 | 2025-12-02 | Warnings | LKG8494WBH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.